Literature DB >> 25318789

Cognitive and affective assessments of multiple sclerosis (MS) and neuromyelitis optica (NMO) patients utilizing computerized touch panel-type screening tests.

Yuko Kawahara1, Masami Ikeda, Kentaro Deguchi, Nozomi Hishikawa, Syoichiro Kono, Yoshio Omote, Kosuke Matsuzono, Toru Yamashita, Yoshio Ikeda, Koji Abe.   

Abstract

OBJECTIVE: Cognitive and affective dysfunctions are important aspects for patients with multiple sclerosis (MS) and neuromyelitis optica (NMO).
METHODS: We herein examined the cognitive and affective ability in MS (n=35) and NMO (n=10) patients using computerized touch panel-type screening tests.
RESULTS: While MS patients and normal controls (NC1, n=40) did not significantly differ in their scores from the Hasegawa dementia scale-revised (HDS-R) or the frontal assessment battery, MS patients did score significantly lower on the mini-mental state examination (MMSE). In contrast, NMO patients did not differ from the normal control group 2 (NC2, n=15) in any of the three cognitive assessments. We also examined the affective ability and found that MS patients scored significantly higher on the apathy scale (AS) compared with the NC1 group, while NMO patients scored significantly higher on the geriatric depression scale (GDS) compared with the NC2 group. Although the GDS and AS scores did not correlate with any of the cognitive assessments among MS patients, the AS scores did correlate with the MMSE and HDS-R among NMO patients. Compared with normal controls, the times to complete the flipping cards and arranging pictures games were significantly longer for MS patients but not for NMO patients.
CONCLUSION: These results indicate differences between some features of cognitive and affective dysfunctions between MS and NMO patients. Computerized touch panel-type screening tests may be a more useful and sensitive tool for the cognitive assessment of MS patients than NMO patients.

Entities:  

Mesh:

Year:  2014        PMID: 25318789     DOI: 10.2169/internalmedicine.53.2571

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Authors:  Velina S Chavarro; Maureen A Mealy; Alexandra Simpson; Anna Lacheta; Florence Pache; Klemens Ruprecht; Stefan M Gold; Friedemann Paul; Alexander Ulrich Brandt; Michael Levy
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-10-24

2.  Computerized neuropsychological assessment devices in multiple sclerosis: A systematic review.

Authors:  Curtis M Wojcik; Meghan Beier; Kathleen Costello; John DeLuca; Anthony Feinstein; Yael Goverover; Mark Gudesblatt; Michael Jaworski; Rosalind Kalb; Lori Kostich; Nicholas G LaRocca; Jonathan D Rodgers; Ralph Hb Benedict
Journal:  Mult Scler       Date:  2019-10-22       Impact factor: 6.312

3.  Cognitive Impairment in Neuromyelitis Optica.

Authors:  Ahmet Yabalak; Burcu Altunrende; Gülşen Akman Demir
Journal:  Noro Psikiyatr Ars       Date:  2020-04-24       Impact factor: 1.339

4.  Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder.

Authors:  Lingyao Kong; Yanlin Lang; Xiaofei Wang; Jiancheng Wang; Hongxi Chen; Ziyan Shi; Hongyu Zhou
Journal:  Front Neurol       Date:  2022-09-16       Impact factor: 4.086

Review 5.  Cognitive impairment in NMOSD-More questions than answers.

Authors:  Dominika Czarnecka; Magdalena Oset; Iwona Karlińska; Mariusz Stasiołek
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.